Medication info

Dapagaregn 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
28 tablets/box [(7 tablets/PTP X 4)], 90 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202300422 · Approved 2023.01.31

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, when administered in combination with metformin, the recommended initial dose of this medicine is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine is not recommended to improve glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control abnormalities
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used in combination with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications. Special caution is needed in patients who do not sufficiently control blood sugar and have cardiovascular diseases or risk factors, as there is a risk of cardiovascular events. This medication improves blood sugar control in type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, when administered in combination with metformin, the recommended initial dose of this medicine is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine is not recommended to improve glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used by individuals allergic to the active ingredient or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Individuals with hereditary lactose intolerance or related diseases should also not take this medication. Patients undergoing dialysis treatment should not use this medication. Caution is needed when using this in patients with low fluid volume or impaired renal function, as there is a risk of hypotension or kidney damage, and the status should be closely monitored before and after administration. This medication is not recommended for patients with significantly decreased kidney function for blood sugar control purposes. When taking this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and ketoacidosis may occur, and immediate consultation with a doctor is required if symptoms appear. Genital infections are more common in women, and those with a history of past infections are at a higher risk of recurrence. Hypoglycemia may occur more frequently when used together with medications like insulin or sulfonylureas, so caution is needed. If symptoms of decreased fluid volume or hypotension occur, temporary discontinuation of this medication may be considered. Diabetic ketoacidosis can occur even with normal blood sugar levels, so any symptoms like nausea, vomiting, abdominal pain, or difficulty breathing should lead to immediate testing. This medication is not recommended for patients with severely impaired liver function. Elderly patients or those on diuretics should be cautious due to a higher risk of decreased fluid volume and hypotension. While taking this medication, glucose may be detected in urine tests, so please be aware of this. If used with insulin or insulin secretagogues, dose adjustments may be necessary to minimize the risk of hypoglycemia. This medication is not recommended for pregnant or breastfeeding women and should be discontinued if pregnancy is confirmed. Safety and efficacy in children have not yet been established. There is no specific antidote in case of overdose, and appropriate treatment should be provided according to symptoms. This medication does not significantly affect driving or operating machinery, but caution should be exercised for hypoglycemic symptoms when taken with insulin or sulfonylurea.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, diminished fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar pruritus, genital pruritus, elevated hematocrit, initial reduction in renal creatinine clearance during treatment, dyslipidemia, initial increase in blood creatinine during treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulitis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, hesitancy, urolithiasis, abnormal urination, increased blood lactate, lymphocytopenia, vitamin D deficiency, decreased appetite, paresthesia, dysgeusia, drowsiness, tension-type headache, carpal tunnel syndrome, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremors, bronchitis, shingles, sinusitis, tonsillitis, herpes simplex, sty, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like illness, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweats, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, muscle weakness, contusion, traffic accident, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscal tear, skin abrasion, tendon rupture, thoracic spine fracture, tibial fracture, dental injury, dry eye, eye pain, retinal disorder, vision loss, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorder, epistaxis, obstructive sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, auditory hallucinations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to keep the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

28 tablets/box [(7 tablets/PTP X 4)], 90 tablets/bottle, 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.